Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, October 19, 2023
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
[ Thu, Oct 19th 2023
] - WOPRAI
Oren Livnat Maintained (CARA) at Strong Buy with Decreased Target to $7 on, Oct 19th, 2023
Oren Livnat of HC Wainwright & Co., Maintained "Cara Therapeutics, Inc." (CARA) at Strong Buy with Decreased Target from $15 to $7 on, Oct 19th, 2023.
Oren has made no other calls on CARA in the last 4 months.
There are 4 other peers that have a rating on CARA. Out of the 4 peers that are also analyzing CARA, 0 agree with Oren's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Oren
- David Amsellem of "Piper Sandler" Maintained at Buy with Decreased Target to $12 on, Tuesday, August 8th, 2023
- Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $22 on, Tuesday, August 8th, 2023
- Annabel Samimy of "Stifel" Reiterated at Strong Buy and Held Target at $28 on, Tuesday, June 27th, 2023
- Dennis Ding of "Jefferies" Reiterated at Strong Buy and Held Target at $18 on, Tuesday, June 27th, 2023
